© Reuters. GSK logo is seen in this illustration taken on January 17, 2022. REUTERS/Dado Ruvic/Illustration
(Reuters) – British drugmaker GSK said on Monday its vaccine, Priorix, was approved by the U.S. Food and DrugAdministration (FDA) for the prevention of measles, mumps and rubella for those aged one year and above.
“We’re proud to make Priorix available in the U.S. for the first time, adding a choice for providers to help protect patients against these highly-contagious diseases,” GSK Head of U.S. Vaccines Judy Stewart said.
Be the first to comment